RxDoctor Payments DataLook up a doctor →

CUVITRU: payments to doctors

Payments that named CUVITRU as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$2M
Providers
6,817
Transactions
39,362
Average per transaction
$51

The per-transaction average — $51 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,817 providers the average total is $296, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$1,898,07794.2%
Shire North American Group Inc$117,5905.8%
← All drugs & devices